Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/231418
Authors: 
Grumiller, Jan
Grohs, Hannes
Year of Publication: 
2021
Series/Report no.: 
ÖFSE Briefing Paper No. 29
Abstract: 
This Briefing Paper examines the resilience of the medical product and pharmaceutical global value chains. Based on this assessment, policy recommendations are presented to increase supply security, including measures to improve the resilience of supply chains, and to expand stockpiling. We also highlight that industrial policy measures to promote reshoring should play a more important role, and that coordination on the EU-level is necessary. Given the large differences between products and supply chains within and between sectors, policies need to be tailored to specific products and product groups. Finally yet importantly, repercussions of EU policy on the Global South also need to be taken into account.
Subjects: 
supply chain resilience
reshoring
pharmaceuticals
medical products
COVID-19
Document Type: 
Research Report

Files in This Item:
File
Size
490.71 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.